TrialBMC pulmonary medicine2017

Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease.

Pierre-Régis Burgel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.